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AGGLUTINATION of the erythrocytes of human cancer patients (Green, Wake-
field and Littlewood, 1957; Betts et al., 1962; Anthony and Parsons, 1965), of
tumour-bearing hamsters (Betts et al. 1961) and of tumour-bearing rats (Green,
Wakefield and Littlewood, 1957) by antiserum to normal serum globulins has
been reported. It is an atypical Coombs' reaction which has been called the
erythroagglutination reaction (Betts et al., 1964). Agglutination of cancer
patients' erythrocytes was not demonstrable with the commercial antiglobulin
antisera (anti-y- and anti-non-y-) tested, and was lost from laboratory-prepared
antiglobulin antiserum as it aged while the anti-D titre was unaffected
(Anthony and Parsons, 1965). Some workers have failed to elicit the reaction
(Beilby, 1958) while others have demonstrated the reaction only with antisera
to the glubulins of cancer patients (Gelhorn, 1960; Sohier, Juranies and Aub,
1957). The suggestion of Beilby (1958) that the reaction demonstrated the
adsorption of cold agglutinin can be discounted since it has been demonstrated
with erythrocytes preparedimmediately in the warm (Anthonyand Parsons, 1965).
The transplanted RD3 tumour grows progressively to kill the host in 12-14
days when grown in ascites form in Sheffield Wistar rats, maintained as a closed
colony. In about halfthe rats the erythroagglutination reaction becomes positive
2 or 3 days before death. The nature of the erythrocyte coating substance
contributing to this reaction has been investigated.
MATERIALS AND METHODS
Erythrocyte agglutination
Anti-rat globulin serum was prepared in rabbits by the method of Dunsford
andBowley (1955).
An incomplete anti-erythrocyte antibody was prepared in rats by immunising
with crude lipid, prepared by chloroform-methanol extraction ofrabbit erythrocyte
stroma, suspended in rabbit serum. The most satisfactory antiserum wasobtained
from rats immunised by subcutaneous injection of 2-4 mg. lipid in 0.5 ml. rabbit
serum and 0 5 ml. Freund's complete adjuvant, boosted with 1-2 mg. lipid in
serum and adjuvant a week later and bled after a month. This caused no haemo-
lysis or haemagglutination of rabbit erythrocytes after heat inactivation at 56° C.
for 30 minutes. Satisfactory sensitisation was obtained by incubation of a 5%
suspension of rabbit erythrocytes for 1 hour at 370 C. with serum diluted 1 in 10.
These erythrocytes were used as a positive control.ERYTHROCYTE COATING SUBSTANCE
Normal rat and rabbit erythrocytes were included as negative controls.
Erythrocytes were washed three times in isotonic saline before use. The test
was performed using doubling dilutions of antiglobulin serum on a white tile
which was gently rocked. The result was read after 5 minutes.
Preparation of the erythrocyte coating substance (ECS)
Rats showing a positive erythroagglutination reaction (agglutination to a
titre of 1 in 4 or more) were exsanguinated from the heart or thoracic cavity.
The blood was collected into citrated saline, the erythrocytes separated by gentle
centrifugation (200 g), washed 6 times in isotonic saline and resuspended at 20%.
Smears of the erythrocyte suspension showed negligible contamination with
tumour cells. Elution was carried out by incubating the erythrocyte suspension
at 56° C. for 20 minutes with occasional inversion of the tube, followed by
immediate centrifugation in buckets containing water preheated to 56° C. The
sediment was discarded.
On other occasions, eluate was prepared from erythrocyte stroma. The
erythrocytes were lysed by suspension in progressively increasing dilutions of
saline in distilled water; Sodium chloride was added to the suspension of stroma
to restore isotonicity before centrifugation (6250 g for 20 minutes). The sedi-
mented stroma was washed twice in large volumes of isotonic saline and resus-
pended in the volume of saline which would have given a 20% suspension of the
original unlysed erythrocytes. After elution as above, the erythrocyte stroma
was spun off at 6250 g and the sediment discarded.
Preparation of antiserum to ECS
Rabbits were given 4 weekly intramuscular injections of 1 ml. of ECS in an
equal volume of Freund's complete adjuvant, followed by 3 intravenous injec-
tions of 0-5 ml. ECS on alternate days, and bled 9 days after the last injection.
Individual rabbits were immunised with ECS prepared either from lysed or from
whole erythrocytes.
Absorption ofantisera
Antisera were absorbed with an equal volume of packed normal rat erythro-
cytes (1 hour at 370 C.) and with either liver, serum or tumour powder at 10
mg./ml. (1 hour at 37° C. and 18 hours at 40 C.). Liver and tumour were passed
through progressively finer stainless steel gauzes and washed 6 times in saline
and twice in distilled water before lyophilisation; serum was dialysed against
distilled water for 18 hours at 40 C. and lyophilised.
Preparation of tumour coating substance (TCS)
The ascites tumour RD3 was drained from the peritoneal cavity with a large
bore needle and the cells collected by gentle centrifugation. The supernatant
was recentrifuged (800 g for 5 minutes) and the fibrin clot allowed to form. The
ascitic fluid (AsF) was drawn off for use in gel diffusion. The cells were re-
suspended in distilled water to lyse the contaminating erythrocytes and the
tumour cells washed 4-6 times in isotonic saline. A 20% suspension was used for
elution of tumour coating substance (TCS) as described for erythrocytes.
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Immunodiffusion
Immunodiffusion (see Ouchterlony, 1962) was carried out using a 1% solution
of Ionagar No. 2 (Oxoid) in isotonic saline with or without the addition of 0.2%
sodium azide, in petri dishes and on microscope slides. Gels were kept in a moist
atmosphere at room temperature and inspected regularly. Large gels were
recorded as contact prints on photographic paper at or before the 4th day. Small
gels were enlarged directly on to photographic paper, using diffused light, at
20 hours. Gels were subsequently washed in saline followed by distilled water,
dried at 370 C. and stained with naphthol black.
The antigens used were ECS, TCS, the serum (AsS) and the ascitic fluid (AsF)
of ascites tumour-bearing rats, normal rat serum (NS) and reconstituted pure
rat IgG globulin (kindly provided by Immunology Inc. ofChicago). The reactions
were compared to those with anti-rat globulin serum.
Immunoelectrophoresis
Microelectrophoresis of serum and ascitic fluid was carried out by the method
of Wieme (1959) using barbitone buffer pH 8-4, ionic strength 0.1. Satisfactory
separation on two slides coveredwith 0-75 mm. of0.8% agar in buffer was obtained
using a 30 minute run at 150 v, 40-5Q mA. After application of the antiserum,
gels were developed in a moist atmosphere at room temperature and recorded
at 20hours.
RESULTS
Agglutination of erythrocytes of tumour-bearing rats was not detected using
anti-eluate serum E.
When unabsorbed antiserum (E) to erythrocyte coating substance (ECS)
was tested in gel diffusion against ECS, there was a broad band of precipitation
which showed a reaction of identity with components of normal serum. This
band was less marked when antiserum prepared from lysed erythrocytes was used,
or when the ECS used on the plate had been prepared from lysed erythrocytes.
EXPLANATION OF PLATES
FIG. 1 and 2.-Central Well; E, anti-ECS serum.
Peripheral Wells; NS, normal serum; AsS, AsF, serum and ascitic fluid of tumour-
bearing rat diluted where indicated; ECS, erthrocyte coating substance; TCS, tumour-
coating substance.
FIG. 3 and 4.-Antiserum in side wells; E-S, anti-ECS serum absorbed with freeze dried serum;
E-T,anti-ECS serum absorbedwithtumourpowder; E-L, anti-ECS serum absorbed with liver
powder. In each instance the antiserum had also been absorbed with erythrocytes.
Antigens: IgG, reconstituted Jyophilised pure rat IgG (kindly provided by Immunology
Inc. of Chicago). AsS, AsF, serum and ascitic fluid of tumour-bearing rat; TCS, tumour-
coating substance.
FIG. 5 and 6.-Antiserum in side wells; E, anti-ECS serum; ARG, anti-rat globulin serum,
diluted where indicated.
Antigens; IgG, reconstituted lyophilised pure rat IgG; AsS, AsF, serum and ascitic fluid
oftumour-bearing rat, diluted where indicated; TCS, tumour-coating substance.
FIG. 7. Immunoelectrophoretic pattern.
Top slide: topwell, normal serum; bottom well, serum of tumour-bearing rat. Antiserum,
anti-rat globulin serum.
Bottom slide:topwell,normal serum; bottom well, tumour-coating substance. Antiserum,
anti-ECS serum.
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It was absent when the antiserum had been absorbed with normal erythrocytes
and liverpowder (E-L).
A fine line, often double, to a slower-moving component ofECS was not affected
by such absorption. It showed a reaction of identity with a component of
tumour coating substance (TCS) and of the serum (AsS) and the ascitic fluid
(AsF) of tumour-bearing rats (Fig. 1) and a reaction of partial identity with
reconstituted pure rat IgG globulin. No appreciable deviation of this line on
approaching the well containing fresh normal serum was detected, but clear
deviation occurred near the well containing serum from a tumour-bearing rat
(AsS) diluted 1 in 10 (Fig. 2), indicating that the difference in concentration ofthis
component in the two sera was at least ten-fold. The line was reduced or removed
by prior absorption ofthe antiserum with either serum powder or tumour powder.
The presence of this line after absorption with normal erythrocytes and liver
powder (E-L) and its reduction after absorption with serum powder (E-S) or
tumour powder (E-T) is shown in Fig. 3 and 4. It will be noted that the anti-
serum absorbed with serum powder (E-S) acts as an additional source of antigen
to the antiserum absorbed with liver powder (E-L). This was a regular finding.
Fig. 4 also demonstrates the reaction of partial identity with reconstituted IgG
globulin.
When the reactions ofthe antiserum E were compared to that ofrabbit anti-rat
globulin serum (ARG), there was fusion of a line due to a component capable of
reacting with both antisera (Fig. 5 and 6). This showed identity with the compo-
nent of reconstituted IgG with which the E antiserum reacted. This was shown,
from its reaction with ARG antiserum, to be a minor, faster-moving component
ofreconstituted IgG (Fig. 5).
On immunoelectrophoresis additional lines have been noted in the x- and
/3-regions when the serum and ascitic fluid of tumour-bearing rats have been
allowed to react with anti-rat globulin serum. Weak lines in the a or , position
have also appeared on development with anti-ECS serum. The top slide of Fig. 7
shows additional lines in the x- and fl-regions of ascitic serum (bottom well) not
detectable in normal serum (top well) when reacting with anti-rat globulin serum.
The lower pattern is that produced by the reaction of TCS with anti-ECS serum;
a weak line is detectable in the fl-region. Normal serum (top well) gave rise to no
lines against this antiserum.
CONCLUSIONS
These reactions indicate that the erythrocyte coating substance (ECS) of rats
bearing the RD3 ascites tumour and showing a positive erythroagglutination
reaction contains an altered globulin. The line of partial identity is with a minor
component of reconstituted pure rat IgG not detectable in fresh normal serum.
Demonstration ofthe same antigen in the serum and ascitic fluid oftumour-bearing
rats rules out artefactual denaturation in the process of elution as the source of
alteration of the globulin. The alteration must therefore have occurred in vivo
either by aggregation, by partial degradation or by combination with antigen.
For a variety of reasons, the latter seems the most likely explanation. The
antigen forms a clear reaction of partial identity with the altered component of
IgG. Although the line is commonly double, no significant separation of the
line has been achieved, and only one line has been detected on immunoelectro-
phoresis using anti-ECS serum absorbed with liver and erythrocytes. The line
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was reduced or absent on gel-diffusion using anti-ECS serum absorbed with either
tumour or freeze dried serum.
The similarity of reaction patterns and the reactions of complete identity of
this antigen in ECS, in tumour-coating substance (TCS) and in the serum and
ascitic fluid of tumour-bearing rats indicates that the same antigen is present at
at all these sites. It gives no indication of the origin of the complex.
The absence ofthe complex from normal erythrocytes (as shown by absorption)
and the reaction of partial identity of the lines due to the complex detected with
anti-eluate and anti-globulin antisera suggest that it is the protein responsible
for the atypical agglutination. This could not be confirmed by direct agglutina-
tion of the erythrocytes of tumour-bearing rats using anti-ECS serum.
An atypical Coombs' reaction has been reported in the presence of a high
reticulocyte count, and has been shown to be dependent on the presence of trans-
ferrin onl immature erythrocytes (Jandl, 1960). The agglutinated clumps were
normally not visible with the naked eye and were almost exclusively composed
of reticulocytes. Transferrin is unlikely to be responsible for the erythroagglu-
tination reaction in the tumour-bearing rat for a variety of reasons. The agglu-
tination was always read with the naked eye. The complex detected showed
partial identity with a component of freeze-dried serum, was not detected in
normal serum but was present in increased amounts in the serum oftumour-bearing
rats. By contrast low serum transferrin levels have been noted in cancer patients
(Bariety and Gajdos, 1960; Masuya et al., 1963) and in the presence of anaemia
due to blood loss or iron deficiency (Masuya et al., 1963). Raised serum trans-
ferrin has been reported in rats bearing hepatomata (Clausen et al., 1960), consis-
tent with the presumed hepatic origin of transferrin. In addition, the fact that
the complex oni the erythrocytes was immunologically identical with and com-
parable in concentration to the substance coating the tumour cells is not consistent
with it being transferrin.
This slowly-diffusing complex with electrophoretic characteristics of a
fl-globulin would seem to be distinct from the rapidly diffusing serum glycoproteini
described by Darcy (1960, 1965) in the serum of rats with tumours and those with
tissue injury or necrosis. Ifthe complex describedisanantigen-antibody complex,
as it appears to be, it may, in this non-syngeneic situation, be the result of a host
response to transplantation antigens rather than a response to the tumour qua
tumour. This could not be the case in the apparently comparable situation in
the humani cancer patient.
SITMMARY
Trhe nature of the erythrocyte coating substance contributing to the positive
erythroagglutination reaction in rats bearing the RD3 ascites tumour has been
investigated using gel diffusion and immunoelectrophoresis. The results indicate
that it is immunologically identical with a component oftumour coating substance,
and of the serum and ascitic fluid of tumour-bearing rats, and that it contains an
altered globulin.
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